These 3 ASX 200 shares were just rerated by top brokers

Brokers just changed their views on these three ASX 200 shares. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Three S&P/ASX 200 Index (ASX: XJO) just got rerated by leading brokers.

One had its outlook cut.

The other two received boosted forecasts.

Read on for the details.

(Broker data courtesy of The Australian.)

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements

Image source: Getty Images

One ASX 200 share getting downgraded

First, we turn to the ASX 200 share getting its rating cut today, software designer Altium Ltd (ASX: ALU).

Altium shares are down 0.1% in early trade today, changing hands for $67.48 apiece. That sees the Altium share price up 45% in 2024. The stock also trades on a partly franked trailing dividend yield of 0.9%.

Much of this year's strong performance stems from February's $9.1 billion takeover offer lobbed by Japan's Renesas Electronics Corporation. An offer the board supports and one that's headed for a shareholder vote.

The takeover offer values Altium at $68.50 per share.

That also happens to be Citi's price target for the stock. The broker doesn't appear to see any further upside from there and has cut this ASX 200 share's rating to neutral.

Two large caps getting upgrades

Moving onto the ASX 200 shares earning upgrades, we kick off with iron ore miner Champion Iron Ltd (ASX: CIA).

The Champion Iron share price is up 0.9% in morning trade today at $6.66. But following on this year's slide in iron ore prices, Champion Iron share remain down 22% in 2024. The stock also trades on an unfranked trailing dividend yield of 2.3%.

Macquarie believes that the sell-off has been overdone.

The broker raised Champion Iron to an outperform rating with a $7.90 price target. That represents a potential upside of almost 19% from current levels.

The miner released some promising FY 2024 results on 31 May. Among the highlights, the company achieved all-time high earnings before interest, taxes, depreciation and amortisation (EBITDA) of C$553, an 11% increase from the prior year.

Which brings us to the second ASX 200 share getting a broker upgrade, Aussie oil and gas giant Woodside Energy Group Ltd (ASX: WDS).

The Woodside share price is up 1.4% today, at $27.46 a share. That still leaves the stock down 13% in 2024. And it sees Woodside shares trading at a fully franked trailing yield of 7.9%.

According to Macquarie equities analyst Mark Wiseman, Woodside shares are now trading at bargain levels. Macquarie raised Woodside shares to an outperform rating with a $32.00 price target (unchanged). That represents a potential upside of almost 17% from current levels.

According to Wiseman, Woodside shares have been oversold based on excessive concerns over the company's project and climate risks.

On the project risk front, yesterday the ASX 200 share reported it had achieved its first oil from the offshore Sangomar project in Senegal. Sangomar is one of the company's major growth projects that's come under scrutiny following government elections in the African nation in March.

According to Wiseman (quoted by The Australian):

We see upside potential from the ramp-up of the Sangomar project, ability to book additional reserves. In 12 to 24 months Woodside can determine whether a phase 2 project is viable.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Altium and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX share tips from 4 brokers, for returns better than 40%

These shares are ripe for a re-rating the analysts say.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

2 ASX mining shares to sell: experts

Experts say it's time to sell these ASX mining shares after an impressive run in FY26.

Read more »

A man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
Broker Notes

Buy, hold, sell: Weebit Nano, Metals X, Pro Medicus shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Young boy with glasses in a suit sits at a chair and reads a newspaper.
Broker Notes

Sell Judo shares and 2 other ASX small caps: experts

ASX small-cap shares outperformed the broader market in FY26, but experts are calling time on these 3 stocks. Here's why.

Read more »

A young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Broker Notes

Buy, hold, sell: SKS Technologies, Yancoal, Wesfarmers shares

Let's check out some new ratings on ASX shares today.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Wisetech Global, CBA shares

Experts explain their ratings on 3 ASX 200 shares. 

Read more »

A female athlete in green spandex leaps from one cliff edge to another.
Broker Notes

Up 149% in a year, why this surging ASX 300 tech stock is still a good buy today

One expert weighs in.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Broker Notes

Up 75%, are Pro Medicus shares still a good buy now?

A leading analyst provides his forecast for Pro Medicus shares.

Read more »